Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Day One Biopharmaceuticals (DAWN) Other Operating Expenses (2024 - 2025)

Historic Other Operating Expenses for Day One Biopharmaceuticals (DAWN) over the last 2 years, with Q3 2025 value amounting to $4.5 million.

  • Day One Biopharmaceuticals' Other Operating Expenses rose 18176.1% to $4.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.1 million, marking a year-over-year increase of 51432.3%. This contributed to the annual value of $5.3 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Day One Biopharmaceuticals' Other Operating Expenses is $4.5 million, which was up 18176.1% from $3.8 million recorded in Q2 2025.
  • Day One Biopharmaceuticals' Other Operating Expenses' 5-year high stood at $4.5 million during Q3 2025, with a 5-year trough of $707000.0 in Q2 2024.